![Per Gunnar Falk](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Per Gunnar Falk
President chez Ferring Pharmaceuticals A/S
Postes actifs de Per Gunnar Falk
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ferring Pharmaceuticals A/S
![]() Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Directeur Technique/Scientifique/R&D | 01/02/2015 | - |
President | 01/01/2019 | - |
Historique de carrière de Per Gunnar Falk
Anciens postes connus de Per Gunnar Falk
Sociétés | Poste | Début | Fin |
---|---|---|---|
Novo Nordisk North America, Inc. | Directeur Technique/Scientifique/R&D | 03/01/2011 | 03/01/2011 |
Conseiller Juridique Général | 03/01/2011 | 03/01/2011 | |
INNATE PHARMA | Directeur/Membre du Conseil | 04/03/2013 | - |
NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2002 | - |
Molecular Biology Consultants | Directeur/Membre du Conseil | - | - |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Directeur/Membre du Conseil | 01/01/1998 | - |
Astra Hässle AB | Directeur/Membre du Conseil | - | - |
Umea Universitet | Corporate Officer/Principal | - | - |
University of Gothenburg | Corporate Officer/Principal | - | - |
░░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de Per Gunnar Falk
University of Gothenburg | Doctorate Degree |
Statistiques
Internationale
Suède | 7 |
Etats-Unis | 4 |
Danemark | 3 |
Opérationnelle
Director/Board Member | 5 |
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
NOVO NORDISK A/S | Health Technology |
INNATE PHARMA | Health Technology |
Entreprise privées | 7 |
---|---|
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Ferring Pharmaceuticals A/S
![]() Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Health Technology |
Gastrointestinal Associates PC
![]() Gastrointestinal Associates PC Medical/Nursing ServicesHealth Services Gastrointestinal Associates PC provides treatment for gastrointestinal problems. The private company is based in Knoxville, TN. | Health Services |
Molecular Biology Consultants | |
Novo Nordisk North America, Inc. | |
Recopharma AB
![]() Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Health Technology |
Astra Hässle AB |
- Bourse
- Insiders
- Per Gunnar Falk
- Expérience